Mirae Asset Global Etfs Holdings Ltd. Cytokinetics Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Cytokinetics Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 72,310 shares of CYTK stock, worth $4.12 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
72,310
Previous 74,918
3.48%
Holding current value
$4.12 Million
Previous $3.01 Million
20.63%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
370Shares Held
129MCall Options Held
3.62MPut Options Held
1.14M-
T. Rowe Price Investment Management, Inc. Baltimore, MD17.6MShares$1 Billion0.37% of portfolio
-
Black Rock Inc. New York, NY14.7MShares$836 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$683 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA7.83MShares$446 Million0.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$363 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.36B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...